CUBT
Curative Biotechnology Inc
NYSE MKT: CUBT · HEALTHCARE · BIOTECHNOLOGY
$0.83
-0.06% today
Updated 2026-10-29
Market cap
$1.07B
P/E ratio
—
P/S ratio
158.53x
EPS (TTM)
$-0.72
Dividend yield
—
52W range
$0 – $1
Volume
0.0M
Curative Biotechnology Inc (CUBT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+29.2%
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2023-03-31 | — | $-0.00 | — | — | — |
| 2022-12-31 | — | $-0.00 | — | — | — |
| 2022-09-30 | — | $-0.00 | — | — | — |
| 2022-06-30 | — | $-0.00 | — | — | — |
| 2022-03-31 | — | $-0.00 | — | — | — |
| 2021-12-31 | — | $-0.00 | — | — | — |
| 2021-09-30 | — | $-0.00 | — | — | — |
| 2021-06-30 | — | $-0.00 | — | — | — |
| 2021-03-31 | — | $-0.00 | — | — | — |
| 2020-12-31 | — | $-0.00 | — | — | — |
| 2020-09-30 | — | $0.00 | — | — | — |
| 2020-06-30 | — | $0.00 | — | — | — |
Frequently asked questions
Has Curative Biotechnology Inc beaten earnings estimates?
Curative Biotechnology Inc has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.